• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Plasma Levels of Human Chitinase 3-like 1 (chi3l1), a Proangiogenic Protein, Are Persistently Elevated During the First Month After Minimally Invasive Colorectal Cancer Resection

Plasma Levels of Human Chitinase 3-like 1 (chi3l1), a Proangiogenic Protein, Are Persistently Elevated During the First Month After Minimally Invasive Colorectal Cancer Resection

H.m.c Shantha Kumara, PhD, Hiromichi Miyagaki, MDPhD, Xiaohong Yan, PhD, Sonali A C. Hearth, BS, Elizabeth Myers, MD, Sahani De Silva, Vesna Cekic, RN, Richard L Whelan, MD. Division of Colon and Rectal Surgery, Department of Surgery, St Luke’s-Roosevelt Hospital Center, Suite 7B, 425 West, 59th Street, New York, NY 10019, USA;Department of Gastroenterological surgery, Graduate school of Medicine, Osaka University..

Introduction:
Blood levels of at least 6 proangiogenic proteins, including VEGF, monocyte chemotactic protein-1(MCP-1), and Interleukin-8(IL8), have been shown to be elevated for 2-4 weeks after minimally invasive colorectal resection (MICR). Chitinase 3-like 1 (CHI3L1) protein, also known as YKL-40, is a member of the Chitinase family of proteins and has chemotactic and proangiogenic effects similar to those of MCP-1 and IL8. This study’s goal was to assess blood levels of CHI3L1 for 2 months after MICR (lap. assisted or hand-assisted) for colorectal cancer (CRC). Tumor expression of CHI3L1 has been noted in patients with colon, breast, and hepatocellular carcinoma. CHI3L1 regulates cellular and tissue responses via IL-13 receptor alpha 2. CHI3L1 may utilize its chitin binding ability to communicate with other signal transduction pathways to modulate inflammation, apoptosis, tissue remodeling, cell growth and angiogenesis. CHI3L1 promotes in vitro cancer cell proliferation, macrophage recruitment, human endothelial cell migration and tube formation, and contributes to wound healing. The impact of MICR for CRC on plasma levels of CHI3L1 is unknown.

Method:
Patients enrolled in an IRB approved data/plasma bank who underwent elective MICR for CRC for whom adequate plasma samples were available were included. The prospectively gathered clinical, demographic, pathologic and short term outcome data were reviewed. Blood samples were collected preoperatively (PreOp) and at a variety of post operative (PostOp) time points. Plasma was isolated and stored at -80°C. Late samples were bundled into 7 day blocks and considered as single time points. CHI3L1 levels (ng/ml) were determined in duplicate via ELISA and results reported as mean± SD. The paired t-test was used for statistical analysis (significance p<0.008 after Bonferroni correction).

Results:
PreOp and, at least, 1 late postoperative plasma sample were available for 80 MICR cancer patients (colonic 60%; rectal 40%; 42 males /38 females, mean age 65.6± 12.8 years). The mean incision length was 7.8± 3.6 cm, mean operative time 308.3± 124.2min, and mean length of stay was 6.6± 4.3days. The final cancer staging breakdown was; Stage I, 25%, Stage II, 31.3%, stage III, 40% and stage IV, 3.7%. The mean PreOp CHI3L1 level was 93.3± 108.9ng/ml (n=80). When compared to PreOp levels significantly elevated (p<0.0001) mean CHI3L1plasma levels (mg/ml) were detected on POD1 (679.7± 405.2; n=79), POD 3 (204.7± 221.9, n=76), POD7-13 (182.9± 201.5, n=62), POD14-20 (225.3± 222.2, n=22, p=0.001), and POD 21-27 (145.0± 212.6., n=20, p=.002). No significant difference in plasma levels were noted on POD27-41 (vs. PreOp,n= 15,p=0.011).

Discussion:
Plasma CHI3L1 levels are significantly elevated over PreOp levels for a month after MICR for CRC. The increased blood levels during the early postoperative period may be associated with the short lived acute inflammatory response that occurs after surgery and resolves in the first week. In contrast, the later and persistent elevation noted during weeks 2-4 after MICR may be related to wound healing. Persistently elevated CHI3L1 levels, together with the similarly increased levels of the other proangiogenic proteins mentioned, may collectively promote the growth of residual tumor after MICR.

View Poster

145

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals